These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 4978447)

  • 1. A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects.
    Seidel D; Alaupovic P; Furman RH
    J Clin Invest; 1969 Jul; 48(7):1211-23. PubMed ID: 4978447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins.
    Seidel D; Alaupovic P; Furman RH; McConathy WJ
    J Clin Invest; 1970 Dec; 49(12):2396-407. PubMed ID: 5480863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lipoprotein characterizing obstructive jaundice: isolation and analysis.
    Furman RH; Seidel D; Alaupovic P
    Trans Am Clin Climatol Assoc; 1970; 81():98-106. PubMed ID: 5000578
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigation of the abnormal low-density lipoproteins occurring in patients with obstructive jaundice.
    Kostner GM; Laggner P; Prexl HJ; Holasek A
    Biochem J; 1976 Aug; 157(2):401-7. PubMed ID: 183749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein abnormalities in cholestasis. I. Electrophoretic and ultracentrifugal analyses.
    Watanabe M
    Acta Med Okayama; 1979 Aug; 33(4):269-85. PubMed ID: 227230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Abnormal lipoprotein (LP-X) in the first months of life with particular reference to obstructive jaundice (author's transl)].
    Lachmann D
    Wien Klin Wochenschr Suppl; 1977; 69():3-28. PubMed ID: 266315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein-X.
    Narayanan S
    CRC Crit Rev Clin Lab Sci; 1979 Aug; 11(1):31-51. PubMed ID: 389551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of the quantitative assay of lipoprotein X in the differential diagnosis of extraphepatic obstructive jaundice and intrahepatic diseases.
    Magnani HN; Alaupovic P
    Gastroenterology; 1976 Jul; 71(1):87-93. PubMed ID: 179911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human plasma lipoproteins.
    Alaupovic P; Lee DM; McConathy WJ
    Biochim Biophys Acta; 1972 Apr; 260(4):689-707. PubMed ID: 4337564
    [No Abstract]   [Full Text] [Related]  

  • 10. A method for the quantitative determination of the abnormal lipoprotein (LP X) of obstructive jaundice.
    Magnani HN; Alaupović P
    Clin Chim Acta; 1972 May; 38(2):405-11. PubMed ID: 4337344
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemistry and clinical relevance of lipoprotein X.
    Narayanan S
    Ann Clin Lab Sci; 1984; 14(5):371-4. PubMed ID: 6476782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An abnormal low-density lipoprotein in cholestases. I. Isolation and characterization].
    Seidel D; Alaupovic P
    Dtsch Med Wochenschr; 1970 Aug; 95(35):1774-80. PubMed ID: 4989048
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation and partial characterization of two abnormal human plasma lipoproteins: LP-X1 and LP-X2.
    Patsch JR; Patsch W; Sailer S; Braunsteiner H
    Biochim Biophys Acta; 1976 Jun; 434(2):419-27. PubMed ID: 821525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sturucture of an abnormal plasma lipoprotein (LP-X) characterizing obstructive jaundice.
    Seidel D; Agostini B; Müller P
    Biochim Biophys Acta; 1972 Jan; 260(1):146-52. PubMed ID: 4622266
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma lipoproteins in patients with familial plasma lecithin: cholesterol acyltransferase (LCAT) deficiency--studies on the apolipoprotein composition of isolated fractions with identification of LP-X.
    Seidel D; Gjone E; Blomhoff JP; Geisen HP
    Horm Metab Res; 1974; Suppl 4():6-11. PubMed ID: 4371225
    [No Abstract]   [Full Text] [Related]  

  • 16. The isolation of lipoproteins from human plasma by ultracentrifugation in zonal rotors.
    Wilcox HG; Davis DC; Heimberg M
    J Lipid Res; 1971 Mar; 12(2):160-72. PubMed ID: 4101815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay of beta lipoprotein-protein of rat serum.
    Eaton RP; Kipnis DM
    J Clin Invest; 1969 Aug; 48(8):1387-96. PubMed ID: 4978731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma lipoprotein changes in experimental cholestasis in the dog.
    Danielsson B; Ekman R; Johansson BG; Petersson BG
    Clin Chim Acta; 1977 Oct; 80(1):157-70. PubMed ID: 198165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultracentrifugal characterization of a lipoprotein occurring in obstructive jaundice.
    Mills GL; Seidel D; Alaupovic P
    Clin Chim Acta; 1969 Nov; 26(2):239-44. PubMed ID: 4982019
    [No Abstract]   [Full Text] [Related]  

  • 20. Properties of the abnormal human plasma lipoprotein (LP-X) characteristic of cholestasis after chemical modification with succinic anhydride.
    Jonas A; Seidel D
    Arch Biochem Biophys; 1974 Jul; 163(1):200-10. PubMed ID: 4369076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.